85 related articles for article (PubMed ID: 28270725)
21. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
[TBL] [Abstract][Full Text] [Related]
23. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
24. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
[TBL] [Abstract][Full Text] [Related]
25. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.
Myers RE; Hyslop T; Gerrity M; Schlackman N; Hanchak N; Grana J; Turner BJ; Weinberg D; Hauck WW
Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):587-93. PubMed ID: 10428195
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the effect of an audit and feedback reporting tool on screening participation: The Primary Care Screening Activity Report (PCSAR).
Jonah L; Pefoyo AK; Lee A; Hader J; Strasberg S; Kupets R; Chiarelli AM; Tinmouth J
Prev Med; 2017 Mar; 96():135-143. PubMed ID: 27923667
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
Wong CK; Lam CL; Wan YF; Fong DY
BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
[TBL] [Abstract][Full Text] [Related]
28. Gastroenterologists' practice patterns for positive fecal occult blood test.
Kim JJ; Han A; Yan AW; Cao D; Laine L
J Clin Gastroenterol; 2014 Feb; 48(2):119-26. PubMed ID: 23632353
[TBL] [Abstract][Full Text] [Related]
29. Physician-patient communication about colorectal cancer screening.
Wolf MS; Baker DW; Makoul G
J Gen Intern Med; 2007 Nov; 22(11):1493-9. PubMed ID: 17851721
[TBL] [Abstract][Full Text] [Related]
30. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
[TBL] [Abstract][Full Text] [Related]
32. An audit of the utility of in-patient fecal occult blood testing.
Sharma VK; Komanduri S; Nayyar S; Headly A; Modlinger P; Metz DC; Verghese VJ; Wanahita A; Go MF; Howden CW
Am J Gastroenterol; 2001 Apr; 96(4):1256-60. PubMed ID: 11316179
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
34. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
35. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy?
Lang CA; Ransohoff DF
JAMA; 1994 Apr; 271(13):1011-3. PubMed ID: 8139058
[TBL] [Abstract][Full Text] [Related]
36. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.
Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814
[TBL] [Abstract][Full Text] [Related]
37. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
38. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
Sharma VK; Corder FA; Fancher J; Howden CW
Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
[TBL] [Abstract][Full Text] [Related]
39. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
40. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]